Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
fda
3
×
ipo
3
×
life sciences
national blog main
new york blog main
new york top stories
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deerfield management
detroit blog main
detroit top stories
drug discovery
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
melinta therapeutics
national
national top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
What
ipo
medicines
3
×
bio
covid
roundup
acquisitions
activity
announced
approvals
biogen
ceo
clamped
collabs
company’s
course
daniel
deal
delays
developing
development
discover
economic
experimental
fast
fda
gilead
gilead’s
growing
handiwork
help
helped
including
internal
introduce
isn’t
landscape
lot
month
new
oric’s
Language
unset
Current search:
medicines
×
ipo
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline